Comorbid substance use disorder (SUD) was documented in 15.1% of patients (n = 766), with numerically higher rates among FGA-initiated patients (17.7%) compared to SGA-initiated patients (14.9%), though this difference did not reach statistical significance (p = 0.116).
← all excerpts
Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates.
2
0.1160
0.1160
The sentences
The accelerated LAI adoption in recent cohorts is a positive trend that should be sustained and expanded beyond treatment-resistant populations.